Thermo Fisher Scientific launches its TurboTox GC/MS, designed to maximise performance while minimising costs in high-throughput toxicology laboratories testing urine samples for drugs of abuse
The new Thermo Scientific TurboTox GC/MS offers a complete, integrated platform comprised of the Thermo Scientific DSQ IITM single quadrupole GC/MS system, ToxLab 2.0 software, and GC/MS methods and consumables, all brought together to ensure lowest cost per test, with maximum uptime and unmatched linearity, precision and intelligent sequencing.
The US Substance Abuse and Mental Health Services Administration (Samhsa) workplace drug testing programme currently requires that GC/MS methods be used for confirmation of five drug classes.
The methods included in the TurboTox GC/MS have been fully validated in urine matrix for linearity, precision and specificity to ensure full compliance with these accepted practices.
The TurboTox GC/MS is said to be the first validated, total solution to be introduced to the market to include both standard operating procedures and consumables, extending from sample preparation through to sample analysis, resulting in utmost analytical confidence.
ToxLab 2.0 software offers unparalleled intelligent sequencing, for optimal productivity and operational efficiency.
ToxLab continuously monitors batches and modifies the batch as needed in real time.
Users establish the level of intelligence required and ToxLab performs appropriate actions.
Whether it is preventing carryover, re-injecting for ion ratio failures, or checking peak symmetry, ToxLab automates time-consuming processes and increases efficiency in the lab.
The TurboTox allows users to enjoy the benefits of the DSQ II GC/MS instrument, including its high sensitivity and high upper limit of linearity, and ToxLab 2.0 software which reduces the need for costly retests when specimens quantitate outside of the instrument's linear range.
